These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1106 related articles for article (PubMed ID: 872039)

  • 21. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
    Woodruff MF; Warner NL
    J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma.
    Woodruff MF; Hitchcock E; Whitehead VL
    Br J Cancer; 1977 May; 35(5):687-92. PubMed ID: 861152
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of anaerobic coryneforms on specific and non-specific immunological reactions. I. Effect on particle clearance and humoral and cell-mediated immunological responses.
    O'Neill GJ; Henderson DC; White RG
    Immunology; 1973 Jun; 24(6):977-95. PubMed ID: 4717941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
    Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
    Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
    [No Abstract]   [Full Text] [Related]  

  • 26. Regression of a transplantable hamster melanoma by intralesional injections of Corynebacterium granulosum.
    Paslin D; Dimitrov NV; Heaton C
    J Natl Cancer Inst; 1974 Feb; 52(2):571-3. PubMed ID: 4593141
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
    Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
    Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth and treatment of B 16 melanoma in hyperglycemic mice.
    Pavelić J; Benković B; Pavelić K
    Res Exp Med (Berl); 1980; 177(1):71-8. PubMed ID: 7403688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between beige and bg/+ mice in the disruption of plasma proteinase regulation in the tumor-bearing state or following Corynebacterium parvum treatment. Evidence for the involvement of polymorphonuclear leukocyte proteinases.
    Hart DA
    Haemostasis; 1988; 18(3):154-62. PubMed ID: 3053356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of BCG and Corynebacterium Parvum on allograft survival after rabbit antimouse lymphocyte serum and donor bone marrow.
    Clark AW; Monaco AP
    Surg Forum; 1973; 24():340-3. PubMed ID: 4618660
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of BCG and C. parvum treatment on human melanoma xenografts.
    Garrett AJ; Reeson DE; Osborn TW; Boulger LR
    Dev Biol Stand; 1977 Apr 13-15; 38():363-8. PubMed ID: 608525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of various coryneforms on mononuclear phagocyte system function and on production of tumour necrosis factor in mice.
    Bloksma N; de Leeuw R; Hofhuis FM; Westerdaal NA; Benaissa-Trouw B; Willers JM
    Ann Immunol (Paris); 1983; 134C(1):159-64. PubMed ID: 6190428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
    Likhite VV; Halpern BN
    Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
    [No Abstract]   [Full Text] [Related]  

  • 36. Active immunization of rats against two tumoral ascites using live cells associated with Corynebacterium parvum.
    Lupu A
    Arch Roum Pathol Exp Microbiol; 1987; 46(2):167-71. PubMed ID: 3455654
    [No Abstract]   [Full Text] [Related]  

  • 37. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 40. Proceedings: Therapy of methyl cholanthrene induced CBA mouse tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Aug; 32(2):241. PubMed ID: 1212356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.